Johnson & Johnson is Undervalued. Forward PE 15

Johnliu08
2021-10-20

"Johnson & Johnson ($Johnson & Johnson(JNJ)$ ) reported sales of $23.3 billion for the third quarter, up 10.7% from the same quarter last year. Adjusted earnings were $2.60 per share, up 18.2% from a year ago."

This news accounts for the nice pop in share price of over 3%.

It's Undervalued. Forward PE 15

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法